(Q47273203)

English

Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2.

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

1 reference

based on heuristic

inferred from title

Daniel J. Hicklin

8

object named as

Daniel Hicklin

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

author name string

Haifan Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Yiwen Li

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Hongli Li

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Rajiv Bassi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Xenia Jimenez

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Larry Witte

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Peter Bohlen

7

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Zhenping Zhu

9

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

45

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

9

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

1887-1897

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Molecular and biological properties of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Inhibition of vascular endothelial growth factor in the treatment of solid tumors

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

General aspects of anti-angiogenesis and cancer therapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Bone marrow angiogenesis and progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Angiogenesis in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

KDR receptor: a key marker defining hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001712225

21 January 2018

Identifiers

10.1080/10428190410001712225

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/15223651

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47273203&oldid=1559607028"